Volume 20, Number 6—June 2014
Dispatch
Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
Table
Camel | Age | Anti–MERS CoV titers |
Anti–bovine CoV titers |
|||
---|---|---|---|---|---|---|
Nov 14 | Dec 9 | Nov 14 | Dec 9 | |||
A | 13 y | 40,960 | 81,920 | |||
B | 3 mo | 640 | 2,560 | 320 | 1,280–2,560 | |
C | 12 y | 20,480 | 20,480 | |||
D | 9 y | 40,960 | 40,960 | |||
E | 13 y | 5,120 | 5,120 | |||
F | 8 y | 40,960 | 40,960 | |||
G† | 8 mo | 640 | 2,560 | <10 | <10 | |
H | 8 mo | 40,960 | 40,960 | |||
I | 2 y | 5,120 | 5,120 |
*MERS, Middle East respiratory syndrome; CoV, coronavirus.
†For camel G, a sample taken on November 9 was also available and yielded an immunofluorescence titer of 320.
Page created: March 20, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.